Dasatinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dasatinib and local guidelines before prescribing.

Tyrosine kinase inhibitor

Mechanism

BCR-ABL and SRC tyrosine kinase inhibitor.

Uses

Chronic myeloid leukaemia, Ph-positive ALL.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myelosuppression, pleural effusion, pulmonary hypertension, bleeding, QT prolongation.

Interactions

PPIs and H2 blockers reduce absorption; CYP3A4 interactions.

Contraindications and cautions

Hypersensitivity

Monitoring

FBC, ECG, CXR if dyspnoea

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

Monitor for pleural effusion; BCR-ABL PCR.

More from the textbook: uses, cautions and other points
Where it is discussed in the book